ClinVar Miner

Submissions for variant NM_019616.4(F7):c.995C>T (p.Ala332Val) (rs36209567)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
NIHR Bioresource Rare Diseases, University of Cambridge RCV000012857 SCV000899413 pathogenic Factor VII deficiency 2019-02-01 criteria provided, single submitter research
NIHR Bioresource Rare Diseases, University of Cambridge RCV000851974 SCV000899414 likely pathogenic Abnormal bleeding 2019-02-01 criteria provided, single submitter research
Illumina Clinical Services Laboratory,Illumina RCV000012857 SCV000915624 pathogenic Factor VII deficiency 2018-08-15 criteria provided, single submitter clinical testing The F7 c.1061C>T (p.Ala354Val) missense variant, previously known as p.Ala294Val, has been reported in more than seven studies in which it is found in a total of more than 97 alleles in individuals with factor VII deficiency, including 10 homozygotes and four compound heterozygotes (Bernardi et al. 1994; Wulff et al. 2000; Fromovich-Amit et al. 2004; Mariani et al. 2005; Marty et al. 2008; Branchini et al. 2012; Pavlova et al. 2015). Of note, this variant is also described in cis with a second variant, c.11128delC, in an additional 111 alleles in affected individuals, including 26 individuals homozygous for both variants. The p.Ala354Val variant was absent from 20 controls, but is reported at a frequency of 0.00128 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional analysis of FVII activity in the plasma of a homozygous individual carrying this variant and the second variant, c.11128delC, showed drastically reduced activity. In vivo studies of the p.Ala354Val variant identified decreased activation of FX by variant FVII protein; however, functional studies showed discordant results when evaluating alterations in the variant protein's interaction with activators and cofactors (Toso et al. 2002; Fromovich-Amit et al. 2004; Branchini et al. 2012). Based on the evidence, the p.Ala354Val variant is classified as pathogenic for factor VII deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
CeGaT Praxis fuer Humangenetik Tuebingen RCV001091742 SCV001247947 pathogenic not provided 2019-10-01 criteria provided, single submitter clinical testing
Centre for Mendelian Genomics,University Medical Centre Ljubljana RCV000012857 SCV001368367 likely pathogenic Factor VII deficiency 2019-09-11 criteria provided, single submitter clinical testing This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM1,PM2,PP3,PP5.
Invitae RCV001091742 SCV001586999 pathogenic not provided 2020-04-15 criteria provided, single submitter clinical testing This sequence change replaces alanine with valine at codon 354 of the F7 protein (p.Ala354Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs36209567, ExAC 0.1%). This variant has been reported as homozygous or compound heterozygous in many individuals and families affected with factor VII deficiency (PMID: 7981691, 7919338, 10862079, 15735798). This variant is also known as Ala294Val in the literature. ClinVar contains an entry for this variant (Variation ID: 12076). Individuals who carried this variant in addition to a second variant had low factor VII activity in blood samples, suggesting that this variant impairs protein function (PMID: 7981691, 7919338, 10862079, 15735798). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000012857 SCV000033098 pathogenic Factor VII deficiency 2000-01-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.